Cargando…
T cell dysregulation in inflammatory diseases in ICU
Severe inflammatory diseases, including sepsis, are characterized by an impaired host adaptive and innate immunity which results in immunosuppression, responsible for secondary infections and increased morbidity and mortality in critically ill patients. T cells are major actors of the immune system....
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590394/ https://www.ncbi.nlm.nih.gov/pubmed/36279072 http://dx.doi.org/10.1186/s40635-022-00471-6 |
_version_ | 1784814502429065216 |
---|---|
author | Luperto, Marta Zafrani, Lara |
author_facet | Luperto, Marta Zafrani, Lara |
author_sort | Luperto, Marta |
collection | PubMed |
description | Severe inflammatory diseases, including sepsis, are characterized by an impaired host adaptive and innate immunity which results in immunosuppression, responsible for secondary infections and increased morbidity and mortality in critically ill patients. T cells are major actors of the immune system. During post-aggressive immunosuppression, lymphopenia, reduction of innate T cells, changes in T helper cell polarization and regulatory T cell increase are observed. The main mechanisms involved in T cell dysregulation are T cell apoptosis, autophagy deficiency, T cell anergy, T cell exhaustion and T cell metabolic reprogramming. In this review, we describe the alterations of T cell regulation, their mechanisms, and their association with clinical outcomes in severe inflammatory diseases, foremost of which is the sepsis. |
format | Online Article Text |
id | pubmed-9590394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-95903942022-10-24 T cell dysregulation in inflammatory diseases in ICU Luperto, Marta Zafrani, Lara Intensive Care Med Exp Reviews Severe inflammatory diseases, including sepsis, are characterized by an impaired host adaptive and innate immunity which results in immunosuppression, responsible for secondary infections and increased morbidity and mortality in critically ill patients. T cells are major actors of the immune system. During post-aggressive immunosuppression, lymphopenia, reduction of innate T cells, changes in T helper cell polarization and regulatory T cell increase are observed. The main mechanisms involved in T cell dysregulation are T cell apoptosis, autophagy deficiency, T cell anergy, T cell exhaustion and T cell metabolic reprogramming. In this review, we describe the alterations of T cell regulation, their mechanisms, and their association with clinical outcomes in severe inflammatory diseases, foremost of which is the sepsis. Springer International Publishing 2022-10-24 /pmc/articles/PMC9590394/ /pubmed/36279072 http://dx.doi.org/10.1186/s40635-022-00471-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Reviews Luperto, Marta Zafrani, Lara T cell dysregulation in inflammatory diseases in ICU |
title | T cell dysregulation in inflammatory diseases in ICU |
title_full | T cell dysregulation in inflammatory diseases in ICU |
title_fullStr | T cell dysregulation in inflammatory diseases in ICU |
title_full_unstemmed | T cell dysregulation in inflammatory diseases in ICU |
title_short | T cell dysregulation in inflammatory diseases in ICU |
title_sort | t cell dysregulation in inflammatory diseases in icu |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590394/ https://www.ncbi.nlm.nih.gov/pubmed/36279072 http://dx.doi.org/10.1186/s40635-022-00471-6 |
work_keys_str_mv | AT lupertomarta tcelldysregulationininflammatorydiseasesinicu AT zafranilara tcelldysregulationininflammatorydiseasesinicu |